Cargando…

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice

Detalles Bibliográficos
Autores principales:	Piroth, Marc D., Krug, David, Fastner, Gerd, Sedlmayer, Felix, Budach, Wilfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154799/ https://www.ncbi.nlm.nih.gov/pubmed/33891127 http://dx.doi.org/10.1007/s00066-021-01775-4

Ejemplares similares

Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward
por: Krug, David, et al.
Publicado: (2021)

Current controversies in radiotherapy for breast cancer
por: Krug, David, et al.
Publicado: (2017)

Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
por: Fastner, Gerd, et al.
Publicado: (2022)

Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention
por: Piroth, Marc D., et al.
Publicado: (2018)

Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective
por: Piroth, Marc D., et al.
Publicado: (2022)

Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation
por: Zehentmayr, Franz, et al.
Publicado: (2019)

Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review
por: Zehentmayr, Franz, et al.
Publicado: (2020)

DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases
por: Budach, Wilfried, et al.
Publicado: (2015)

Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
por: Roohani, Siyer, et al.
Publicado: (2022)

DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences
por: Harms, Wolfgang, et al.
Publicado: (2016)

Intraoperative radiotherapy (IORT) as boost in breast cancer
por: Sedlmayer, Felix, et al.
Publicado: (2017)

DEGRO practical guidelines: radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer
por: Sedlmayer, F., et al.
Publicado: (2013)

Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
por: Piroth, Marc D., et al.
Publicado: (2020)

Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)
por: Zehentmayr, Franz, et al.
Publicado: (2015)

Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
por: Liuzzi, Raffaele, et al.
Publicado: (2020)

Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases
por: Budach, Wilfried, et al.
Publicado: (2015)

Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer
por: Banfill, Kathryn, et al.
Publicado: (2022)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Risk-adapted moderate hypofractionation of prostate cancer: A prospective analysis of acute toxicity, QOL and outcome in 221 patients
por: Schörghofer, Andreas, et al.
Publicado: (2019)

IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study
por: Ciabattoni, Antonella, et al.
Publicado: (2021)

Correction to: IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study
por: Ciabattoni, Antonella, et al.
Publicado: (2021)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Lung dose analysis in loco-regional hypofractionated radiotherapy of breast cancer
por: Attar, Mohammad A., et al.
Publicado: (2016)

Doses, fractionations, constraints for stereotactic radiotherapy
por: Borghesi, Simona, et al.
Publicado: (2022)

High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
por: Grambozov, Brane, et al.
Publicado: (2022)

Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer
por: Grambozov, Brane, et al.
Publicado: (2019)

Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
por: Lazo, Antonio, et al.
Publicado: (2022)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Challenges and Opportunities for Increasing Adoption of Hypofractionated Radiotherapy in Low- and Middle-Income Countries
por: Joseph, A.O., et al.
Publicado: (2022)

Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model
por: Wang, Weiwei, et al.
Publicado: (2021)

Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens
por: Sudahar, H., et al.
Publicado: (2012)

Boost IORT in Breast Cancer: Body of Evidence
por: Sedlmayer, Felix, et al.
Publicado: (2014)

High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities
por: HUANG, BING-SHEN, et al.
Publicado: (2013)

Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer
por: Borm, Kai J., et al.
Publicado: (2020)

Hypofractionated Low-Dose Radiotherapy Combined with Immune Checkpoint Inhibition in Metastatic Solid Tumors
por: Li, Dongqing, et al.
Publicado: (2021)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_13i6k72an5cin6bh0k37s5us7d